Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Frailty × Ascorbic Acid × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pancreatic Neoplasms 5 Neoplasms 4 Neoplasms by Site 2 Multiple Myeloma 2 Glioblastoma 2 Digestive System Neoplasms 2 Digestive System Diseases 2 Colorectal Neoplasms 2 Adenocarcinoma 2 Urinary Bladder Neoplasms 1 Sarcoma 1 Recurrence 1 Rectal Diseases 1 Polycystic Ovary Syndrome 1 Pancreatic Diseases 1 Obesity 1 Neoplasm Metastasis 1 Myofibroma 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Lung Neoplasms 1 Liver Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Acute 1 Intestinal Neoplasms 1 Intestinal Diseases 1 Inflammation 1 Hodgkin Disease 1 Hemorrhage 1 Gastrointestinal Neoplasms 1

Interventions

Standard of Care 2 Geriatric Assessment 2 peflavit 1 microcrystalline cellulose 1 fisetin 1 epigallocatechin gallate 1 diacetamate 1 Ultrasonography 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Quercetin 1 Nutrition Assessment 1 Methods 1 Flavonoids 1 Enhanced Recovery After Surgery 1 Data Collection 1 Dasatinib 1 Control Groups 1 Chemotherapy, Adjuvant 1 Ascorbic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06068543 2026-03-06

ReFOCUS2

University of Rochester

Phase 2 Recruiting

Frailty, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡